← Leaderboards
Greg Perlman
State University New York Stony Brook
$2,579,870
Attributed
$2,579,870
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $715.9K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,579,870 · 2
By mechanism
R01$2,141,245 · 1
R21$438,625 · 1
Top collaborators
No co-investigators on record.
Most similar at State University New York Stony Brook
Same institution · by research overlap
- Jodi Jay Weinstein$2,955,190
- Wynne K Schiffer$3,280,984
- Sean Clouston$18,398,213
- Nora D Volkow$1,942,497
- Scott J Moeller$8,130,677
Others in their field
Other Emerging Leaders on “Magnetic Resonance Imaging”
- Susan Abushakra · Alzheon, Inc.$50,765,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Eric C Palm · Florida State University$31,951,397
- Michael W Rabin · Florida State University$26,502,247
- Ross D McDonald · Florida State University$26,502,247
- Bryan Roth · Univ Of North Carolina Chapel Hill$21,325,531
Research focus
Magnetic Resonance ImagingPharmaceutical PreparationsImaging ModalityInvestigationPathway InteractionsPatternFunctional Magnetic Resonance ImagingHigh RiskImaging StudyIndexingNeuromelaninNeuronsAlcohol ConsumptionDopamineAdolescent Substance Use16 Year OldAdultAnabolismChronicChildhoodAge GroupCohortCorpus Striatum StructurePositron-Emission Tomography
Grant awards (5)
Neuromelanin MRI: A tool for non-invasive investigation of dopaminergic abnormalities in adolescent substance use.$715,149
R01 · FY2025 · DA · contact PI
Neuromelanin MRI: A tool for non-invasive investigation of dopaminergic abnormalities in adolescent substance use.$715,884
R01 · FY2024 · DA · contact PI
Neuromelanin MRI: A tool for non-invasive investigation of dopaminergic abnormalities in adolescent substance use.$710,212
R01 · FY2023 · DA · contact PI
Neuromelanin sensitive MRI as a novel, non-invasive index of dopamine function in adolescent-onset substance users$239,250
R21 · FY2020 · DA · contact PI
Neuromelanin sensitive MRI as a novel, non-invasive index of dopamine function in adolescent-onset substance users$199,375
R21 · FY2019 · DA · contact PI